# ACM Research share price today (ACM Research, Inc., ACMR)

> ACM Research, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. ACMR · Technology · Semiconductor Equipment & Materials · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/acmr

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from the last 12 quarters
- Price: $45.33 (+9.3% in a year)
- P/E: 21.2× (higher than 62% of the last 4.6 years)
- Revenue (Jun 2026): $293 M (+36.0% on a year ago)
- Profit (Jun 2026): $89.0 M (+199.0% on a year ago)
- Operating margin: 17.0% (+2.3 points on a year ago)
- ROE: 5%, FY25
- ROIC: 9.9%, against a 14.4% cost of capital: −4.5 points

The main question: profits are rising, but only 24% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the ACM Research share price today? ACM Research, Inc.'s share price was $45.33 at the close on 3 November 2026. It has been moving sideways for 4 weeks. That is 33.8% below its average price over the last 200 trading days. In the last 52 weeks it traded between $30 and $110, and at that close it sat 19% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 11 weeks running. Over the last 9 years the share price moved +2,273% while the S&P 500 moved +192%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 21 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does ACM Research pay? ACM Research, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is ACM Research on? ACM Research is on one of our US lists: US tech stocks. [US tech stocks](https://www.sectoralpha.in/us-tech-stocks)

## Is ACM Research profitable? ACM Research, Inc. earned $89.0 M of net profit in the Jun 2026 quarter, +199.0% on the same quarter a year earlier. Full-year FY25 profit was $94.1 M. Over 4 years profit has grown 25.6% a year on average. That is 30.4% of the quarter's revenue. The same quarter a year earlier earned $29.8 M. For the full year, FY25 profit was $94.1 M (−9.2% on the year before). Why profit moved: revenue changed +36.0% on a year earlier and the margin moved +2.3 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +31.5% and revenue +27.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does ACM Research make, and is it growing? ACM Research, Inc. reported $293 M of revenue in the Jun 2026 quarter, +36.0% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 36.5% a year on average. The last full year, FY25, came in at $901 M. The last four reported quarters add to $1.0 B. FY25 revenue was $901 M, +15.2% on the year before. Recent pace: the last four quarters grew +27.9% on average, against 36.5% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +27.3%, against +22.3% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +34.0%, against +32.9% a year (stabilising). ## How much of every $100 of sales does ACM Research keep? ACM Research, Inc.'s operating margin was 17.0% in the Jun 2026 quarter, 2.3 percentage points higher than the same quarter a year ago. Across 5 years it has been between 12.1% and 19.3%. The latest quarter is within that range. Why the margin moved: operating margin changed +2.3 percentage points on the year while gross margin changed −2.5 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is ACM Research's profit turning into cash? Over the last 3 years, 24% of ACM Research, Inc.'s reported profit came in as cash from its operations, a gap worth watching. In FY25 its operations used $10.3 M of cash, against $94.1 M of profit. After $56.3 M of spending on assets, free cash was −$66.6 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does ACM Research's cash go? ACM Research, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $201 M on assets over the last 3 years. Averaged over those years that is 7.4% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $201 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is ACM Research's P/E ratio, and how does it compare with its own history? ACM Research, Inc.'s P/E is 21.2×, in the middle of its own history: higher than 62% of past readings. Its usual P/E (the middle reading) is 17.9×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −10.6% while the price moved +9.3%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 3 years the price moved +44.3% a year; about +24.5% a year came from earnings growth and about +19.8 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the ACM Research business getting better or worse? ACM Research, Inc.'s business is turning around. EPS growth has swung from −10.9% at its low to +26.8%, rising from a low 1 quarters ago, with ROCE falling at 6.6%. This is based on 12 quarters of 4 measures. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. ## How much does ACM Research earn on its capital? ACM Research, Inc. earned a ROE of 5% in FY25. Its return on capital used (ROIC) is 4.5 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 10.4% net margin and 0.31× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 10.4% net margin × 0.31× asset turnover × 1.49× leverage (assets divided by equity) ≈ 4.8% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 9.9% − 14.4% = −4.5 percentage points. The 14.4% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does ACM Research have too much debt? ACM Research, Inc. has total debt of $349 M against shareholder equity of $2.4 B as of Jun 2026, so its debt is 0.15× its equity, which is very little. Year by year, that ratio went from 0.05 in FY21 to 0.15 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the ACM Research shareholding pattern? 5.7% of ACM Research, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is ACM Research from balance-sheet trouble? For ACM Research, Inc., the Z-score is 3.27. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 3.27 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does ACM Research rank in its industry? 38.6 out of 100, rank 22 of 29 in Semiconductor Equipment & Materials, with 81% of the evidence available. ACM Research, Inc. scores 38.6 out of 100 against the 29 companies it is compared with in Semiconductor Equipment & Materials, ranking 22. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 18 + 11.1 + 7.2 + 2.3 = 38.6. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is ACM Research compared with? ACM Research ranks 22 of 29 Semiconductor Equipment & Materials companies on the 4-Factor Sector Score, with 38.6 out of 100. 1. [ASML Holding N.V.](https://www.sectoralpha.in/us/stocks/asml) ASML · quiet · Most evidence points up · 85% evidence 76.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.6/35 · Revenue 22.5% · Profit 42.4% · Operating margin change 11.6 points · 95% evidence Capital efficiency 21.0/25 · ROCE 44.7% · Operating margin 44.4% · 76% evidence Valuation 13.2/20 · P/E 43.3× · PEG 0.97 · 65% evidence Relative strength 17.0/20 · Lead over its industry 6.6% · Lead over S&P 500 -1% · 1 year 52.6% · 100% evidence · 1 of 12 weeks ahead Exact sum: 25.6 + 21 + 13.2 + 17 = 76.8 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Lam Research Corporation](https://www.sectoralpha.in/us/stocks/lrcx) LRCX · quiet · Most evidence points up · 85% evidence 71.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.2/35 · Revenue 33.4% · Profit 45.4% · Operating margin change 5.6 points · 95% evidence Capital efficiency 21.4/25 · ROCE 50.7% · Operating margin 40% · 76% evidence Valuation 13.0/20 · P/E 46.7× · PEG 0.97 · 65% evidence Relative strength 7.5/20 · Lead over its industry -7% · Lead over S&P 500 -15.3% · 1 year 44.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 29.2 + 21.4 + 13 + 7.5 = 71.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Teradyne, Inc.](https://www.sectoralpha.in/us/stocks/ter) TER · losing its lead · Most evidence points up · 81% evidence 68.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.0/35 · Revenue 57.8% · Profit 100% · Operating margin change 18.9 points · 83% evidence Capital efficiency 20.4/25 · ROCE 36.7% · Operating margin 33.2% · 76% evidence Valuation 11.8/20 · P/E 59.5× · PEG 1.03 · 65% evidence Relative strength 5.2/20 · Lead over its industry -10.4% · Lead over S&P 500 -18.7% · 1 year 47.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 31 + 20.4 + 11.8 + 5.2 = 68.4 · What this means: Earnings are strong; relative strength in its sector is -10.4% and the one-year return is 47.8%. 4. [KLA Corporation](https://www.sectoralpha.in/us/stocks/klac) KLAC · quiet · Evidence leans up · 85% evidence 62.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue 15.8% · Profit 24.1% · Operating margin change 3.3 points · 95% evidence Capital efficiency 21.1/25 · ROCE 44.7% · Operating margin 45% · 76% evidence Valuation 8.7/20 · P/E 48.4× · PEG 1.91 · 65% evidence Relative strength 10.4/20 · Lead over its industry -4.5% · Lead over S&P 500 -12.3% · 1 year 30.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.3 + 21.1 + 8.7 + 10.4 = 62.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [FormFactor, Inc.](https://www.sectoralpha.in/us/stocks/form) FORM · losing its lead · Evidence leans up · 81% evidence 60.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.3/35 · Revenue 18.1% · Profit 100% · Operating margin change 17.8 points · 83% evidence Capital efficiency 15.8/25 · ROCE 12.7% · Operating margin 24.1% · 76% evidence Valuation 4.6/20 · P/E 88.3× · PEG 4.6 · 65% evidence Relative strength 11.9/20 · Lead over its industry 0.5% · Lead over S&P 500 -9.8% · 1 year 85.2% · 100% evidence · 2 of 12 weeks ahead Exact sum: 28.3 + 15.8 + 4.6 + 11.9 = 60.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Kulicke and Soffa Industries, Inc.](https://www.sectoralpha.in/us/stocks/klic) KLIC · quiet · Evidence leans up · 64% evidence 60.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.1/35 · Revenue 44.8% · Profit 100% · Operating margin change 20 points · 62% evidence Capital efficiency 14.3/25 · ROCE 12.5% · Operating margin 20.7% · 76% evidence Valuation 10.1/20 · P/E 54.9× · PEG n/a · 15% evidence Relative strength 11.5/20 · Lead over its industry -1.7% · Lead over S&P 500 -11.7% · 1 year 88.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 24.1 + 14.3 + 10.1 + 11.5 = 60 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Cohu, Inc.](https://www.sectoralpha.in/us/stocks/cohu) COHU · losing its lead · Evidence leans up · 64% evidence 58.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 32.5% · Profit n/a · Operating margin change 15.4 points · 62% evidence Capital efficiency 4.8/25 · ROCE -2.9% · Operating margin 0.6% · 76% evidence Valuation 10.8/20 · P/E 27.1× · PEG n/a · 15% evidence Relative strength 19.6/20 · Lead over its industry 25.9% · Lead over S&P 500 12.6% · 1 year 109.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 23.4 + 4.8 + 10.8 + 19.6 = 58.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Applied Materials, Inc.](https://www.sectoralpha.in/us/stocks/amat) AMAT · quiet · Evidence leans up · 85% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.8/35 · Revenue 7.8% · Profit 35.6% · Operating margin change 3.1 points · 95% evidence Capital efficiency 20.1/25 · ROCE 29% · Operating margin 33.7% · 76% evidence Valuation 11.4/20 · P/E 45.9× · PEG 1.21 · 65% evidence Relative strength 9.0/20 · Lead over its industry -1% · Lead over S&P 500 -10.2% · 1 year 66% · 100% evidence · 1 of 12 weeks ahead Exact sum: 16.8 + 20.1 + 11.4 + 9 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Amkor Technology, Inc.](https://www.sectoralpha.in/us/stocks/amkr) AMKR · quiet · Evidence leans up · 81% evidence 54.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Revenue 17.9% · Profit 82.9% · Operating margin change 4.4 points · 83% evidence Capital efficiency 12.4/25 · ROCE 8.5% · Operating margin 10.5% · 76% evidence Valuation 14.8/20 · P/E 38.5× · PEG 0.68 · 65% evidence Relative strength 2.6/20 · Lead over its industry -26.9% · Lead over S&P 500 -33% · 1 year 8.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 24.8 + 12.4 + 14.8 + 2.6 = 54.6 · What this means: Earnings are strong; relative strength in its sector is -26.9% and the one-year return is 8.2%. 10. [Photronics, Inc.](https://www.sectoralpha.in/us/stocks/plab) PLAB · quiet · Evidence leans up · 85% evidence 53.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.2/35 · Revenue 1.3% · Profit 51.4% · Operating margin change -1.8 points · 95% evidence Capital efficiency 15.2/25 · ROCE 10.9% · Operating margin 21.1% · 76% evidence Valuation 16.0/20 · P/E 10.8× · PEG 0.43 · 65% evidence Relative strength 8.1/20 · Lead over its industry -17.1% · Lead over S&P 500 -21.8% · 1 year 29% · 100% evidence · 1 of 12 weeks ahead Exact sum: 14.2 + 15.2 + 16 + 8.1 = 53.5 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 11. [Entegris, Inc.](https://www.sectoralpha.in/us/stocks/entg) ENTG · losing its lead · Evidence leans up · 81% evidence 53.0 out of 100 Growth Capital Valuation Relative
12. InTest Corporation INTT · turning · Evidence leans up · 64% evidence 52.2 out of 100 Growth Capital Valuation Relative
13. [Qnity Electronics, Inc.](https://www.sectoralpha.in/us/stocks/q) Q · quiet · Evidence leans up · 65% evidence 52.1 out of 100 Growth Capital Valuation Relative
14. [AXT, Inc.](https://www.sectoralpha.in/us/stocks/axti) AXTI · losing its lead · Evidence leans up · 64% evidence 52.0 out of 100 Growth Capital Valuation Relative
15. [IPG Photonics Corporation](https://www.sectoralpha.in/us/stocks/ipgp) IPGP · basing · Evidence leans down · 74% evidence 49.1 out of 100 Growth Capital Valuation Relative
16. [Ambarella, Inc.](https://www.sectoralpha.in/us/stocks/amba) AMBA · quiet · Evidence leans down · 67% evidence 48.0 out of 100 Growth Capital Valuation Relative
17. [Amtech Systems, Inc.](https://www.sectoralpha.in/us/stocks/asys) ASYS · quiet · Evidence leans down · 64% evidence 44.5 out of 100 Growth Capital Valuation Relative
18. [Nova Ltd.](https://www.sectoralpha.in/us/stocks/nvmi) NVMI · basing · Evidence leans down · 81% evidence 43.5 out of 100 Growth Capital Valuation Relative
19. [Onto Innovation Inc.](https://www.sectoralpha.in/us/stocks/onto) ONTO · quiet · Too little evidence to rank firmly · 56% evidence 41.6 out of 100 Growth Capital Valuation Relative
20. [Aehr Test Systems, Inc.](https://www.sectoralpha.in/us/stocks/aehr) AEHR · losing its lead · Evidence leans down · 64% evidence 41.4 out of 100 Growth Capital Valuation Relative
21. [Camtek Ltd.](https://www.sectoralpha.in/us/stocks/camt) CAMT · quiet · Evidence leans down · 81% evidence 40.2 out of 100 Growth Capital Valuation Relative
22. ACM Research, Inc. this page ACMR · quiet · Evidence leans down · 81% evidence 38.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.0/35 · Revenue 27.4% · Profit 33.9% · Operating margin change 2.3 points · 83% evidence Capital efficiency 11.1/25 · ROCE 5.3% · Operating margin 17% · 76% evidence Valuation 7.2/20 · P/E 58.4× · PEG 2.19 · 65% evidence Relative strength 2.3/20 · Lead over its industry -22.6% · Lead over S&P 500 -30.2% · 1 year 45.8% · 100% evidence · 1 of 12 weeks ahead Exact sum: 18 + 11.1 + 7.2 + 2.3 = 38.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 23. [Veeco Instruments Inc.](https://www.sectoralpha.in/us/stocks/veco) VECO · quiet · Evidence leans down · 81% evidence 37.3 out of 100 Growth Capital Valuation Relative
24. [Axcelis Technologies, Inc.](https://www.sectoralpha.in/us/stocks/acls) ACLS · quiet · Evidence leans down · 81% evidence 36.9 out of 100 Growth Capital Valuation Relative
25. [Ichor Holdings, Ltd.](https://www.sectoralpha.in/us/stocks/ichr) ICHR · quiet · Evidence leans down · 64% evidence 35.4 out of 100 Growth Capital Valuation Relative
26. [Ultra Clean Holdings, Inc.](https://www.sectoralpha.in/us/stocks/uctt) UCTT · quiet · Most evidence points down · 64% evidence 34.6 out of 100 Growth Capital Valuation Relative
27. [Daqo New Energy Corp.](https://www.sectoralpha.in/us/stocks/dq) DQ · quiet · Most evidence points down · 64% evidence 33.5 out of 100 Growth Capital Valuation Relative
28. Trio-Tech International TRT · Too little evidence to rank firmly · 0% evidence 50.0 out of 100 Growth Capital Valuation Relative
29. Atomera Incorporated ATOM · quiet · Too little evidence to rank firmly · 49% evidence 38.4 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Semiconductor Equipment & Materials](https://www.sectoralpha.in/us/sectors/semiconductor-equipment-materials), all 29 compared on one page. ## Which companies are close to ACM Research in size? ACM Research is the 16th largest of 26 Semiconductor Equipment & Materials companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Kulicke and Soffa Industries, Inc., AXT, Inc. and IPG Photonics Corporation. Just below it: Axcelis Technologies, Inc., Ambarella, Inc. and Cohu, Inc. ### Semiconductor Equipment & Materials companies close in size

1. [Kulicke and Soffa Industries, Inc.](https://www.sectoralpha.in/us/stocks/klic) $3.8 billion
2. [AXT, Inc.](https://www.sectoralpha.in/us/stocks/axti) $3.3 billion
3. [IPG Photonics Corporation](https://www.sectoralpha.in/us/stocks/ipgp) $3.2 billion
4. ACM Research, Inc. $3.2 billion
5. [Axcelis Technologies, Inc.](https://www.sectoralpha.in/us/stocks/acls) $3 billion
6. [Ambarella, Inc.](https://www.sectoralpha.in/us/stocks/amba) $2.7 billion
7. [Cohu, Inc.](https://www.sectoralpha.in/us/stocks/cohu) $2.4 billion

[All 26 Semiconductor Equipment & Materials companies, largest first](https://www.sectoralpha.in/us/sectors/semiconductor-equipment-materials#all-companies)

### Companies close in size in other industries

1. [Cal-Maine Foods, Inc.](https://www.sectoralpha.in/us/stocks/calm) $3.1 billion · Farm Products
2. [KB Home](https://www.sectoralpha.in/us/stocks/kbh) $3.1 billion · Residential Construction
3. ACM Research, Inc. $3.1 billion
4. [Provident Financial Services, Inc.](https://www.sectoralpha.in/us/stocks/pfs) $3.1 billion · Banks - Regional
5. [Standex International Corporation](https://www.sectoralpha.in/us/stocks/sxi) $3.1 billion · Specialty Industrial Machinery

## What else do people ask about ACM Research? ### What were ACM Research's latest quarterly results? ACM Research, Inc. reported revenue of $293 M and net profit of $89.0 M for the Jun 2026 quarter. Revenue rose 36.0% and profit rose 199.0% compared with a year earlier. Earnings per share were $1.23. The operating margin was 17.0%, 2.3 percentage points higher than a year earlier (as of 3 November 2026). ### What is ACM Research's market cap? ACM Research, Inc.'s market capitalisation is $3.2 B at a stock price of $45.33. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is ACM Research performing? ACM Research, Inc.'s share price has been moving sideways for 4 weeks. In its latest quarter, revenue rose 36.0% and profit rose 199.0% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 11 weeks running (as of 3 November 2026). ### Will ACM Research's stock price go up? This page does not forecast ACM Research, Inc.'s stock price. What it shows instead: the stock price is $45.33, and it has been moving sideways for 4 weeks. Its P/E of 21.2× is higher than 62% of its own last 5 years (as of 3 November 2026). ### Where is ACM Research in its business cycle? ACM Research, Inc.'s FY25 operating margin was 12.1%, against a 5-year range of 12.1% to 19.3%: the low end of its own range, which is often where recoveries start. The latest quarter was 17.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the ACM Research story? The main question: profits are rising, but only 24% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is ACM Research a stock worth studying right now? What the numbers show: ACM Research, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- US tech stocks: https://www.sectoralpha.in/us-tech-stocks

This is research, not advice. We’re not SEBI-registered.